Research develops 'novel' approach to malaria vaccine

Clinical trial testing for a malaria vaccine in a small group of people could begin within 18 months, researchers said.

Doctor Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases said researchers found "a novel and different type of an approach toward a vaccine".

Clinical trials could begin within a year. Credit: Patrick Pleul/DPA/Press Association Images

He added: "It's profoundly important to develop an effective malaria vaccine."

Director of Rhode Island Hospital's Center for International Health Research, doctor Jonathan Kurtis, said researchers found that antibodies sent by the body's immune system, acted on a protein and trapped the parasites inside the red blood cells, blocking the progression of the disease.

Read: Malaria vaccine to be tested within four to six weeks

Advertisement

Malaria vaccine to be tested within four to six weeks

A promising new approach intended to imprison malaria causing parasites inside infected red blood cells has been developed by scientists.